Trisalus Life Sciences Inc.
11/01/2024 | Press release | Distributed by Public on 11/01/2024 14:08
Management Change/Compensation Form 8 K
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Directors; Compensatory Arrangements of Certain Officers. |
(a)
On October 28, 2024, Anil Singhal, Ph.D., informed the Board of Directors (the "Board") of TriSalus Life Sciences, Inc. (the "Company") of his decision to resign from his position as a member of the Board, the Compensation Committee of the Board and the Science and Technology Committee of the Board, effective immediately. Dr. Singhal's resignation is not a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. The Company thanks Dr. Singhal for his exceptional service and invaluable contributions.
(b)
Effective October 29, 2024, Steven Katz, M.D., the Company's Chief Medical Officer, is no longer employed by the Company.